These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31848148)
1. Ranitidine in short supply: why now, and where next? Ryan ME; Barker C; Hawcutt DB Arch Dis Child; 2020 Apr; 105(4):382-383. PubMed ID: 31848148 [No Abstract] [Full Text] [Related]
2. Hypersensitivity reaction to ranitidine: description of a case and review of the literature. Foti C; Cassano N; Panebianco R; Calogiuri GF; Vena GA Immunopharmacol Immunotoxicol; 2009; 31(3):414-6. PubMed ID: 19694603 [TBL] [Abstract][Full Text] [Related]
3. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease]. Simon B; Müller P; Dammann HG Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962 [TBL] [Abstract][Full Text] [Related]
4. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale]. Andersen M; Schou JS Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181 [TBL] [Abstract][Full Text] [Related]
5. Ranitidine v. cimetidine in peptic ulcer. Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213 [No Abstract] [Full Text] [Related]
6. [Ranitidine: a new histamine H2 receptor blockader]. Duan ZB Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):309-12. PubMed ID: 2874962 [No Abstract] [Full Text] [Related]
7. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems]. Grigor'ev PIa; Isakov VA Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004 [No Abstract] [Full Text] [Related]
8. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial. Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089 [TBL] [Abstract][Full Text] [Related]
9. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders]. Tani N; Miwa T Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482 [No Abstract] [Full Text] [Related]
10. [The status of H2-blocker therapy today]. Rameis H Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029 [TBL] [Abstract][Full Text] [Related]
11. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216 [TBL] [Abstract][Full Text] [Related]
12. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia]. Rampello L; Nicoletti G Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922 [TBL] [Abstract][Full Text] [Related]
13. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist. Mohammed R; Mitchell KG; Mackay C Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237 [TBL] [Abstract][Full Text] [Related]
14. Hepatic effects of drugs used in the treatment of peptic ulcer disease. Lewis JH Am J Gastroenterol; 1987 Oct; 82(10):987-1003. PubMed ID: 2889354 [TBL] [Abstract][Full Text] [Related]
15. [Review of histamine H2 receptor antagonists]. García Plaza A; Pascasio Acevedo JM Rev Esp Enferm Apar Dig; 1984 Oct; 66(4):288-94. PubMed ID: 6151218 [No Abstract] [Full Text] [Related]
17. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Sabesin SM Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374 [TBL] [Abstract][Full Text] [Related]
18. Ranitidine: a pilot study in Japan. Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776 [TBL] [Abstract][Full Text] [Related]